New view of dengue fever
Mice with human immune cells help researchers discover how the mosquito-borne virus depletes blood platelets.
New approach to global health challenges
MIT’s Institute for Medical Engineering and Science brings many tools to the quest for new disease treatments and diagnostic devices.
A computer scientist's approach to medicine
Stephanie Seneff is using the novel natural language processing techniques she developed to better understand how drugs and environmental toxins impact human health.
Study shows projected climate change in West Africa not likely to worsen malaria situation
MIT study combines new model of malaria transmission with global forecasts for temperature and rainfall.
DNA damage may cause ALS
New study finds link between neurons’ inability to repair DNA and neurodegeneration.
Detecting early-stage malarial infection
New prototype device recognizes electrical properties of infected cells as signatures of disease.
Controlling contagion by restricting mobility
Study shows that in the face of an epidemic, even moderate government-mandated travel restrictions would slow contagion.
New way to target an old foe: malaria
Engineered liver tissue developed at MIT could help scientists test new drugs and vaccines.
A step closer to artificial livers
Researchers identify compounds that help liver cells grow outside the body.
Evaluating a new way to open clogged arteries
Computational model offers insight into mechanisms of drug-coated balloons.
Hop, skip or jump? Study says no to all of the above
MIT engineers find that in the earliest stages of arthritis, high-impact exercise may worsen cartilage damage.
Research advances therapy to protect against dengue virus
MIT team presents a novel approach to developing a treatment using mutated antibodies.
Study reveals how melanoma evades chemotherapy
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.
Sorting out the structure of a Parkinson’s protein
Computer modeling may resolve conflicting results and offer hints for new drug-design strategies.
MicroRNA detection on the cheap
MIT alumni’s startup provides rapid, cost-effective microRNA profiling, which is beneficial for diagnosing diseases.